Virtual Medicinal Product (VMP) - Tobramycin 300mg/4ml nebuliser liquid ampoules

Name Details

Name Start Date End Date
Name Current Name Tobramycin 300mg/4ml nebuliser liquid ampoules Start Date 01-02-2010 End Date
Previous Name Previous Name Tobramycin 75mg/ml nebuliser liquid 4ml ampoules Start Date 05-01-2009 End Date 31-01-2010

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
4
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Nebuliser liquid
Ontology Form/Route
solutionnebuliser.inhalation
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
J01GB01
BNF Start Date End Date
Current BNF 05010400 Start Date 04-04-2022 End Date
Previous BNF 05010400 Start Date 05-11-2009 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
14801411000001105 05-01-2009

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Tobramycin Based on Ingredient Substance 75 mg 1 ml

Parent Products

  • VTM
    Tobramycin
    • VMP
      (Current) Tobramycin 300mg/4ml nebuliser liqui...
      • AMP

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
56 ampoule 118700 Part VIIIA Category C